PHARMACEUTICAL FORMULATION

(19)

(11)

EP 0 776 205 A1

(12)

(43)	Date of publication:
	04.06.1997 Bulletin 1997/23

(21)	Application number: 95929820.0

(22)	Date of filing: 08.08.1995

(51)

International Patent Classification (IPC):

A61K 9/ 20^{( . )}
A61K 9/ 52^{( . )}
A61K 31/ 43^{( . )}
A61K 45/ 06^{( . )}

A61K 9/ 50^{( . )}
A61K 31/ 42^{( . )}
A61K 45/ 00^{( . )}
A61P 31/ 04^{( . )}

(86)	International application number:
	PCT/EP1995/003150

(87)	International publication number:
	WO 1996/004907 (22.02.1996 Gazette 1996/09)

(84)	Designated Contracting States:
	AT BE CH DE DK FR GB IT LI NL SE

(30)

Priority:

17.08.1994 GB 19940016599

(71)	Applicant: SMITHKLINE BEECHAM PLC
	Brentford, Middlesex TW8 9EP (GB)

(72)	Inventors:
	MERRIFIELD, David R., SmithKline Beecham Pharm Worthing, West Sussex BN18 8QH (GB) WHITE, Steven, SmithKline Beecham Pharmaceut. Worthing, West Sussex BN14 9QH9QH (GB) RIVETT, Ernest L.G., SmithKline Beecham Pharmaceut Worthing, West Sussex BN14 8QH (GB)

(74)	Representative: Connell, Anthony Christopher, et al
	SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court Brentford, Middlesex TW8 9EP Brentford, Middlesex TW8 9EP (GB)

(54)	PHARMACEUTICAL FORMULATION